Benzinga
Novavax Stock Falls Back: What's Going On? - Novavax (NASDAQ:NVAX)
xCruzo Brief
Novavax shares fell Tuesday after surging more than 20% in Monday’s session, with investors likely taking profits following a Russia outbreak headline. The move came after reports of a suspected pneumonic plague case: a 28-year-old anti-plague lab worker died after reportedly being exposed to the pathogen on September 25. The Trump administration is tracking the case, and about 200 contacts remain under watch. Irkutsk Governor Igor Kobzev said those people have not developed symptoms and all tested negative. By Tuesday’s publication, NVAX was down 10.59% to $11.24, near its 52-week high of $13.38.
xCruzo quick-read summary • Source: Benzinga • Read the full article for complete information.





